Professional
Added to YB: 2025-06-27
Pitch date: 2025-04-12
BRKR [neutral]
Bruker Corporation
+13.95%
current return
Author Info
No bio for this author
Company Info
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
Market Cap
$6.3B
Pitch Price
$39.46
Price Target
N/A
Dividend
0.48%
EV/EBITDA
13.94
P/E
-263.80
EV/Sales
2.37
Sector
Life Sciences Tools and Services
Category
growth
BBH Select Series - Mid Cap Fund Portfolio Holding: Bruker Corporation
BRKR (holding update): Declined 28.7% due to slow 2025 outlook from delayed China stimulus, slow biopharma recovery, and government funding cuts affecting academic research clients. Well-diversified across Americas/EMEA/Asia-Pacific with industrial, biopharma, semi-metrology and diagnostics markets beyond academic/government customers.
Read full article (1 min)